Weight loss to improve insulin sensitivity in insulin-resistant individuals
Official title: Reversal of Lipid-Induced Insulin Resistance
Run by Yale University · NCT02193295 · Data updated 2026-11-12
This study is testing if losing a little weight can help lean people who are insulin-resistant and have a family history of type 2 diabetes improve how their bodies handle sugar and fat.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Yale University Academic / other |
| Locations | 2 sites (New Haven, Connecticut and 1 other locations) |
| Status | Recruiting |
| Started | October 2002 |
| Main results expected | October 2034 |
| Study ends | December 2034 |
| Registry record updated | June 22, 2026 |
| Trial ID | NCT02193295 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy, sedentary individuals with insulin resistance and a family history of type 2 diabetes.
✕Probably not a fit
Patients with systemic diseases, diabetes, or a history of eating disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates whether a small weight loss can reduce lipid content in muscle and liver, thereby improving insulin sensitivity in lean, insulin-resistant individuals with a family history of type 2 diabetes. Participants will undergo a series of metabolic assessments, including glucose metabolism and lipolysis measurements, before and after a caloric restriction intervention. The study aims to compare these effects with a control group of individuals without a family history of diabetes, using advanced techniques such as euglycemic hyperinsulinemic clamps and magnetic resonance spectroscopy.
Why it matters
Potential benefit: If successful, this study could lead to effective weight management strategies that improve insulin sensitivity and reduce the risk of type 2 diabetes in at-risk populations.
How similar studies have gone: Other studies have shown promising results in improving insulin sensitivity through weight loss in similar populations, indicating that this approach is supported by existing research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy, sedentary, non-smoking and not taking any medications other than birth control pills. * Hematocrit \>35% * Subjects will have no systemic or organ disease including diabetes. * Subjects will have no history eating disorders. * Women must be using a form of birth control (sexual abstinence, birth control pills, Norplant, IUD or condoms) and will be studied between day 0 and 7 of their menstrual cycle. * Those who are taking birth control pills or have had a hysterectomy may be studied at any time. * Physical activity will be assessed using a standard questionnaire with an activity index cut off at 2.3. Exclusion Criteria: * Any subject, who does not fit the inclusion criteria. Including history of eating disorders, any systemic and organ disease including diabetes. Lactose intolerance Any blood count, clotting abnormalities HYpertriglyceridemeia (TG over 100 mg/dL) * Hematocrit \<35%. * Women of childbearing potential, who are not using contraception (as mentioned above) or who are not abstinent. * Subjects who have a regular exercise regimen will not be enrolled. * Metal implants and/or body piercing, which cannot be removed before the MR studies.
Where it's running
-
Yale Center for Clinical Investigation HRU
New Haven, Connecticut, United States Recruiting -
Magnetic Resonance Research Center (MRRC)
New Haven, Connecticut, United States Enrolling by invitation
Study contacts
- Principal investigator: Kitt Petersen, MD — Yale University
- Study coordinator: Kitt Petersen, MD
- Email: kitt.petersen@yale.edu
- Phone: 203-785-5447
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Prenatal Exercise to See How Cardio or Strength Training Affects Blood Sugar
This study tests whether different types and amounts of exercise during pregnancy can improve blood sugar control in women with gestational diabetes.
-
Alpelisib Challenge Test to measure insulin secretory capacity
Researchers will test a new approach to measure how much insulin the body can produce in people at various weights and with or without insulin resistance, using alpelisib around a meal test.
-
Inositol and Metformin with Mediterranean or Low-Carb Diets in Women with PCOS
This trial tests whether adding inositol, metformin, or folic acid to either a Mediterranean or a low-carbohydrate diet helps women with PCOS and insulin resistance lose weight and improve metabolic markers.
-
Inulin Prebiotic for Perimenopausal Women with Overweight or Obesity
This study tests whether 2 weeks of inulin can affect gut and vaginal microbes, heart health, and muscle health in perimenopausal women who are overweight or obese, using a crossover design.
-
Kodo Millet Porridge and Gut Health in Overweight and Obese Adults
This study tests whether daily intake of Kodo millet porridge for 12 weeks can improve gut bacteria and metabolic health in adults who are overweight or obese.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.